Cargando…
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area
Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accu...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024438/ https://www.ncbi.nlm.nih.gov/pubmed/35458213 http://dx.doi.org/10.3390/nu14081652 |
_version_ | 1784690588341239808 |
---|---|
author | Gramantieri, Laura Gnudi, Federica Vasuri, Francesco Mandrioli, Daniele Fornari, Francesca Tovoli, Francesco Suzzi, Fabrizia Vornoli, Andrea D’Errico, Antonia Piscaglia, Fabio Giovannini, Catia |
author_facet | Gramantieri, Laura Gnudi, Federica Vasuri, Francesco Mandrioli, Daniele Fornari, Francesca Tovoli, Francesco Suzzi, Fabrizia Vornoli, Andrea D’Errico, Antonia Piscaglia, Fabio Giovannini, Catia |
author_sort | Gramantieri, Laura |
collection | PubMed |
description | Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accumulating in the liver and possibly contributing to liver cancer. AFB1-DNA adducts were assayed by immunostaining in liver tissues from three Italian series of twenty cirrhosis without HCC, 131 HCC, and 45 cholangiocarcinoma, and in an AFB1-induced HCC rat model. CD68, TP53 immunostaining, and TP53 RFLP analysis of R249S transversion were used to characterize cell populations displaying AFB1-DNA adducts. Twenty-five HCCs displayed AFB1-adducts both in neoplastic hepatocytes and in cells infiltrating the tumor and non-tumor tissues. Nuclear immunostaining was observed in a few cases, while most cases showed cytoplasmic immunostaining, especially in CD68-positive tumor-infiltrating cells, suggestive for phagocytosis of dead hepatocytes. Similar patterns were observed in AFB1-induced rat HCC, though with higher intensity. Cholangiocarcinoma and cirrhosis without HCC did not displayAFB1-adducts, except for one case. Despite not providing a causal relationship with HCC, these findings still suggest paying attention to detection and control measures for aflatoxins to ensure food safety in low exposure areas. |
format | Online Article Text |
id | pubmed-9024438 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90244382022-04-23 Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area Gramantieri, Laura Gnudi, Federica Vasuri, Francesco Mandrioli, Daniele Fornari, Francesca Tovoli, Francesco Suzzi, Fabrizia Vornoli, Andrea D’Errico, Antonia Piscaglia, Fabio Giovannini, Catia Nutrients Article Aflatoxin B1 (AFB1) is a class 1 carcinogen with an ascertained role in the development of hepatocellular carcinoma (HCC) in high exposure areas. Instead, this study aimed to assay whether chronic/intermittent, low-dose AFB1 consumption might occur in low-exposure geographical areas, ultimately accumulating in the liver and possibly contributing to liver cancer. AFB1-DNA adducts were assayed by immunostaining in liver tissues from three Italian series of twenty cirrhosis without HCC, 131 HCC, and 45 cholangiocarcinoma, and in an AFB1-induced HCC rat model. CD68, TP53 immunostaining, and TP53 RFLP analysis of R249S transversion were used to characterize cell populations displaying AFB1-DNA adducts. Twenty-five HCCs displayed AFB1-adducts both in neoplastic hepatocytes and in cells infiltrating the tumor and non-tumor tissues. Nuclear immunostaining was observed in a few cases, while most cases showed cytoplasmic immunostaining, especially in CD68-positive tumor-infiltrating cells, suggestive for phagocytosis of dead hepatocytes. Similar patterns were observed in AFB1-induced rat HCC, though with higher intensity. Cholangiocarcinoma and cirrhosis without HCC did not displayAFB1-adducts, except for one case. Despite not providing a causal relationship with HCC, these findings still suggest paying attention to detection and control measures for aflatoxins to ensure food safety in low exposure areas. MDPI 2022-04-15 /pmc/articles/PMC9024438/ /pubmed/35458213 http://dx.doi.org/10.3390/nu14081652 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gramantieri, Laura Gnudi, Federica Vasuri, Francesco Mandrioli, Daniele Fornari, Francesca Tovoli, Francesco Suzzi, Fabrizia Vornoli, Andrea D’Errico, Antonia Piscaglia, Fabio Giovannini, Catia Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area |
title | Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area |
title_full | Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area |
title_fullStr | Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area |
title_full_unstemmed | Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area |
title_short | Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area |
title_sort | aflatoxin b1 dna-adducts in hepatocellular carcinoma from a low exposure area |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024438/ https://www.ncbi.nlm.nih.gov/pubmed/35458213 http://dx.doi.org/10.3390/nu14081652 |
work_keys_str_mv | AT gramantierilaura aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT gnudifederica aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT vasurifrancesco aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT mandriolidaniele aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT fornarifrancesca aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT tovolifrancesco aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT suzzifabrizia aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT vornoliandrea aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT derricoantonia aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT piscagliafabio aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea AT giovanninicatia aflatoxinb1dnaadductsinhepatocellularcarcinomafromalowexposurearea |